Equities

Amoeba SA

Amoeba SA

Actions
Basic MaterialsChemicals
  • Price (EUR)0.66
  • Today's Change0.011 / 1.69%
  • Shares traded33.13k
  • 1 Year change+58.65%
  • Beta-0.0711
Data delayed at least 15 minutes, as of Nov 14 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Amoeba SA's net income fell 78.22% from a loss of 8.02m to a larger loss of 14.30m despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-157.91%
Return on equity--
Return on investment-493.45%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Amoeba SA fell by 5.01m. Cash Flow from Financing totalled 4.31m or -- of revenues. In addition the company used 6.50m for operations while cash used for investing totalled 2.81m.
Cash flow per share-0.2618
Price/Cash flow per share--
Book value per share-0.1421
Tangible book value per share-0.1423
More ▼

Balance sheet in EURView more

Amoeba SA has a Debt to Total Capital ratio of 423.08%, a higher figure than the previous year's 7.28%.
Current ratio0.3295
Quick ratio0.2968
Total debt/total equity--
Total debt/total capital4.23
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.